Conditional Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors

Lignende værker

• Prospective Analysis: Relative Survival in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Era of Tyrosine Kinase Inhibitors
  af: Sasaki, Koji, et al.
  Udgivet: (2015)
• Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients with Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-existing Liver and/or Renal Dysfunction
  af: Sasaki, Koji, et al.
  Udgivet: (2015)
• Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia – a propensity score analysis
  af: Sasaki, Koji, et al.
  Udgivet: (2016)
• Prediction for Sustained Deep Molecular Response of BCR-ABL1 Levels in Patients with Chronic Myeloid Leukemia in Chronic Phase
  af: Sasaki, Koji, et al.
  Udgivet: (2017)
• Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study
  af: Jain, Preetesh, et al.
  Udgivet: (2015)